Literature DB >> 3521337

Control of sodium excretion by angiotensin II: intrarenal mechanisms and blood pressure regulation.

J E Hall.   

Abstract

Angiotensin II (ANG II) is one of the body's most powerful regulators of Na excretion, operating through extrarenal mechanisms, such as stimulation of aldosterone secretion, as well as intrarenal mechanisms. Considerable evidence suggests that the intrarenal actions of ANG II are quantitatively more important than changes in aldosterone secretion in the normal day-to-day regulation of Na balance and arterial pressure. ANG II at physiological concentrations increases proximal tubular reabsorption, but further studies are needed to determine whether ANG II also has an important effect on more distal tubular segments. ANG II also markedly constricts efferent arterioles, tending to increase Na reabsorption by altering peritubular capillary physical forces and also helping to prevent excessive decreases in glomerular filtration rate. ANG II may also decrease Na excretion and increase urine concentrating ability by reducing renal medullary blood flow. Regulation of Na excretion by ANG II is closely linked with arterial pressure control and volume homeostasis through the renal pressure natriuresis mechanism. Under many physiological conditions, such as changes in Na intake, ANG II greatly multiplies the effectiveness of the pressure natriuresis mechanism to prevent fluctuations in body fluid volume and arterial pressure. In circumstances associated with circulatory depression, such as decreased cardiac function, reductions in blood pressure and increased ANG II formation cause Na retention until arterial pressure is restored to normal. However, in pathophysiological conditions in which ANG II is inappropriately elevated, increased arterial pressure (hypertension) is required for the kidney to "escape" the potent antinatriuretic actions of ANG II and to return Na excretion to normal via the pressure natriuresis mechanism.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3521337     DOI: 10.1152/ajpregu.1986.250.6.R960

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  72 in total

Review 1.  RGS2: a "turn-off" in hypertension.

Authors:  Thu H Le; Thomas M Coffman
Journal:  J Clin Invest       Date:  2003-02       Impact factor: 14.808

2.  What is the role of the intrarenal renin-angiotensin system in blood pressure control?

Authors:  J E Hall
Journal:  Pediatr Nephrol       Date:  1990-01       Impact factor: 3.714

3.  Overexpression of angiotensin II type I receptor in cardiomyocytes induces cardiac hypertrophy and remodeling.

Authors:  P Paradis; N Dali-Youcef; F W Paradis; G Thibault; M Nemer
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

Review 4.  Renal autoregulation in health and disease.

Authors:  Mattias Carlström; Christopher S Wilcox; William J Arendshorst
Journal:  Physiol Rev       Date:  2015-04       Impact factor: 37.312

5.  Distinct roles for the kidney and systemic tissues in blood pressure regulation by the renin-angiotensin system.

Authors:  Steven D Crowley; Susan B Gurley; Michael I Oliverio; A Kathy Pazmino; Robert Griffiths; Patrick J Flannery; Robert F Spurney; Hyung-Suk Kim; Oliver Smithies; Thu H Le; Thomas M Coffman
Journal:  J Clin Invest       Date:  2005-04       Impact factor: 14.808

6.  Renal proximal tubule angiotensin AT1A receptors regulate blood pressure.

Authors:  Huiping Li; Eric T Weatherford; Deborah R Davis; Henry L Keen; Justin L Grobe; Alan Daugherty; Lisa A Cassis; Andrew M Allen; Curt D Sigmund
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-07-13       Impact factor: 3.619

Review 7.  Stress physiology in marine mammals: how well do they fit the terrestrial model?

Authors:  Shannon Atkinson; Daniel Crocker; Dorian Houser; Kendall Mashburn
Journal:  J Comp Physiol B       Date:  2015-04-26       Impact factor: 2.200

Review 8.  In hypertension, the kidney breaks your heart.

Authors:  Steven D Crowley; Thomas M Coffman
Journal:  Curr Cardiol Rep       Date:  2008-11       Impact factor: 2.931

9.  Genotype-phenotype analysis of angiotensinogen polymorphisms and essential hypertension: the importance of haplotypes.

Authors:  W Scott Watkins; Steven C Hunt; Gordon H Williams; Whitney Tolpinrud; Xavier Jeunemaitre; Jean-Marc Lalouel; Lynn B Jorde
Journal:  J Hypertens       Date:  2010-01       Impact factor: 4.844

10.  Angiotensin II and hypertonicity modulate proximal tubular aquaporin 1 expression.

Authors:  Richard Bouley; Zaira Palomino; Shiow-Shih Tang; Paula Nunes; Hiroyuki Kobori; Hua A Lu; Winnie W Shum; Ivan Sabolic; Dennis Brown; Julie R Ingelfinger; Flavia F Jung
Journal:  Am J Physiol Renal Physiol       Date:  2009-09-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.